TIV

(3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione

Created: 2015-10-20
Last modified:  2021-03-01

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count47
Chiral Atom Count2
Bond Count52
Aromatic Bond Count20
2D diagram of TIV
Toggle HydrogenToggle Labels

Chemical Component Summary

Name(3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
FormulaC23 H19 N3 O2
Molecular Weight369.416
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESCACTVS3.385O=C1NC(=O)[CH]([CH]1c2c[nH]c3ccccc23)c4cn5CCCc6cccc4c56
SMILESOpenEye OEToolkits2.0.4c1ccc2c(c1)c(c[nH]2)C3C(C(=O)NC3=O)c4cn5c6c4cccc6CCC5
Canonical SMILESCACTVS3.385 O=C1NC(=O)[C@H]([C@@H]1c2c[nH]c3ccccc23)c4cn5CCCc6cccc4c56
Canonical SMILESOpenEye OEToolkits2.0.4 c1ccc2c(c1)c(c[nH]2)[C@H]3[C@@H](C(=O)NC3=O)c4cn5c6c4cccc6CCC5
InChIInChI1.03 InChI=1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m0/s1
InChIKeyInChI1.03 UCEQXRCJXIVODC-PMACEKPBSA-N

Drug Info: DrugBank

DrugBank IDDB12200 
NameTivantinib
Groups investigational
DescriptionTivantinib has been investigated in Solid Tumors.
SynonymsTivantinib
Categories
  • Heterocyclic Compounds, Fused-Ring
  • Proto-Oncogene Proteins c-met, antagonists & inhibitors
  • Pyrrolidines
CAS number905854-02-6

Drug Targets

NameTarget SequencePharmacological ActionActions
Hepatocyte growth factor receptorMKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNFTAET...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL2103882
PubChem 11494412
ChEMBL CHEMBL2103882
ChEBI CHEBI:91398